Αρχική World News FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET... World News FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion-Positive Solid Tumours Από Ogkologos - 2 Σεπτεμβρίου, 2026 133 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the LIBRETTO-001 and LIBRETTO-121 studies Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? MOST POPULAR Adding Neoadjuvant and Adjuvant Pembrolizumab to Standard Care Significantly Improves EFS... 7 Ιουλίου, 2025 ΥΓΡΗ ΒΙΟΨΙΑ: ΤΟ ΜΕΛΛΟΝ ΣΤΗ ΔΙΑΓΝΩΣΗ ΤΟΥ ΚΑΡΚΙΝΟΥ 26 Νοεμβρίου, 2018 ‘Dance Moms’ Star Abby Lee Miller Opens Up About Her Cancer... 19 Απριλίου, 2019 Addressing Common Concerns Around Taking Opioids for Cancer-Related Pain: An Expert... 5 Ιουλίου, 2023 Φόρτωση περισσοτέρων HOT NEWS New study to investigate breast cancer in ethnic minority groups Adding Atezolizumab to First-Line Bevacizumab Plus Platinum Regimen Improves Survival in... Self-care Isn’t Selfish Can Artificial Intelligence–Driven Chatbots Correctly Answer Questions about Cancer?